Jonathan McNeill - Chief Business Officer at Dyne Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
DYN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jonathan McNeill - trading volume in the past year for Dyne Therapeutics, Inc.

Holdings reported by Jonathan McNeill for Dyne Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 134,811 $4.22 M $31.34 Jun 11, 2024 Direct
Stock option (right to buy) 0 Mar 11, 2024 Direct Common Stock

Transactions reported by Jonathan McNeill for Dyne Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership